Biomaterials Enhanced Simulation Testing
Discovering predictive data of your product?
Less costs and lead time? Higher clinical relevancy?
More ethical value? Regulatory compliance?
Take them all - with BEST.
Novel solutions for biomaterials, medical devices and products
BEST progress to-date:
The first Seqvera US patent for advanced biomaterials testing method has been granted!
Gold Sponsor of 2019 Conference of Scandinavian Biomaterials Society (Långvik, Finland, June 2019)
Recent publication (open access) on tailoring of compliance of scaffolds for articular cartilage repair gathers a great impact - exceeding 2,500 views!
Agreement with a medical service company in application of BEST for development of therapy of mental disorders
Became a partner for COST CA17116 network (2018-2021) for research, regulative and translational work of perinatal derivatives as tissue engineering products
Seqvera has confirmed "AA" credit Alfa-rating in Finland (Suomen Asiakastieto Oy)
Expanded to the Terkko Health Hub - right in the heart of Helsinki University Central Hospital, Helsinki - the second largest healthcare center in the world, combining 23 hospitals.
BEST method has successfully demonstrated benefits in veterinary practice - results presented at European Biomaterials Society congress 2017 in Athens: optimization for the robust yet effective biomaterial scaffold for articular cartilage regeneration! See more stories at BEST Cases
Seqvera and Netzsch Gerätebau GmbH (Germany) have entered into cooperation agreement enabling production, adaptation and worldwide supply of the high-precision hardware platforms for BEST